Shanghai Labway Clinical Laboratory Co. Ltd. announced that at the AGM was held on 26 May 2023, the company approved cash dividend/10 shares (tax included): CNY 3.0000000 for 2022.
Shanghai Labway Clinical Laboratory Co., Ltd
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.26 CNY | -2.66% | -4.91% | -22.80% |
1st Jan change | Capi. | |
---|---|---|
-22.80% | 583M | |
-16.80% | 8.79B | |
+64.71% | 4.19B | |
-4.03% | 2.48B | |
-42.54% | 2.29B | |
-6.06% | 1.97B | |
-20.12% | 1.56B | |
-41.24% | 1.22B | |
+10.26% | 1.13B | |
+18.74% | 933M |
- Stock Market
- Equities
- 301060 Stock
- News Shanghai Labway Clinical Laboratory Co., Ltd
- Shanghai Labway Clinical Laboratory Co., Ltd Approves Cash Dividend for 2022